Skip to main content

Find Clinical Trials

Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,009 public trials 2,034 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Targeting the IPA and Matching for the Non-Inherited Maternal Antigen for Haplo-Cord Transplantation

NCT01810588

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hematologic Malignancies, +12 more
Locations: University of Chicago Medical Center Chicago, Illinois, United States

Weill Cornell Medical College New York, United States

View Trial Details

Completed

Carfilzomib, Clarithromycin (Biaxin®), Lenalidomide (Revlimid®), and Dexamethasone (Decadron®) [Car-BiRD] Therapy for Subjects With Multiple Myeloma

NCT01559935

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Weill Cornell Medical College New York, United States

View Trial Details

Completed

Study of Brexucabtagene Autoleucel (KTE-X19) in Participants With Relapsed/Refractory Mantle Cell Lymphoma (Cohort 3)

NCT04880434

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Banner MD Anderson Cancer Center Gilbert, Arizona, United States

Stanford University Palo Alto, California, United States

University California Los Angeles (UCLA) Santa Monica, California, United States

Sarah Cannon- Denver Denver, Colorado, United States

View all 40 locations

View Trial Details

Completed

Study of BEBT-908 in the Relapsed or Refractory Diffuse Large B-cell Lymphoma Subjects

NCT06074107

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations: Cancer Hospital Chinese Academy of Medical Sciences Beijing, China

View Trial Details

Completed

Precision Medicine Study

NCT06338150

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Mount Sinai Health System New York, United States

View Trial Details

Completed

Natural Killer Cells and Bortezomib to Treat Cancer

NCT00720785

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Bronchial Neoplasms, +40 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Completed

Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC

NCT05510908

Conditions: AIDS Related Lymphoma, AIDS-Related Kaposi Sarcoma, AIDS-Related Malignancy, +58 more
Locations: Moores UCSD Cancer Center La Jolla, California, United States

George Washington University Cancer Center Washington D.C., District of Columbia, United States

University of Miami Miller School of Medicine-Sylvester Cancer Center Miami, Florida, United States

Moffitt Cancer Center Tampa, Florida, United States

View all 16 locations

View Trial Details

Completed

Severe Asthma Research Program

NCT01606826

Conditions: Asthma, Bronchial Diseases, Hemic and Lymphatic Diseases, +15 more
Locations: University of California, San Francisco San Francisco, California, United States

Brigham & Women's Hospital Boston, Massachusetts, United States

Children's Hospital, Boston Boston, Massachusetts, United States

Washington University St Louis, Missouri, United States

View Trial Details

Completed

Romidepsin, CC-486 (5-azacitidine), Dexamethasone, and Lenalidomide (RAdR) for Relapsed/Refractory T-cell Malignancies

NCT04447027

Conditions: Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Completed

A Study of Brentuximab Vedotin and CHP in Frontline Treatment of PTCL With Less Than 10% CD30 Expression

NCT04569032

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

University of Alabama at Birmingham Birmingham, Alabama, United States

Stanford Cancer Center Stanford, California, United States

Stanford Hospital and Clinics, Investigational Drug Services Stanford, California, United States

View all 63 locations

View Trial Details